Scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes; genetic testing, specifically pharmacogenomic testing, analysis, and evaluation of buccal, saliva and other biological samples for the purpose of analyzing how the genetic makeup of an individual affects their response to drugs, improving drug selection and dosage recommendations, selecting initial and subsequent medications, identifying drug-drug interactions, avoiding adverse drug reactions, developing clinical treatment decision support recommendations, and supporting other medical diagnostic products and prescription drugs; analysis of multiple genes and genetic variants and the effect on drug response across multiple therapeutic areas, including but not limited to psychiatry, pain, cardiology, oncology; scientific and technological services in the nature of testing, analysis and evaluation of biological samples for research purposes, research in the field of clinical trials, and research in the field of new drug development and drug repurposing